Skip to content

M Y Balogun

2 papers in the library · 56 citations · publishing 2000-2001

Papers

Sort Most recent Most cited

Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties.

Pharmacology, Biochemistry, and Behavior 2001 Karen K. Szumlinski, R E Haskew, M Y Balogun et al. 28 citations

This study investigated the effects of pretreatment with the putative antiaddictive compound, ibogaine (IBO), and its synthetic derivative, 18-methoxycoronaridine (18-MC), on the changes in behaviour in an elevated plus maze and the changes in corticosterone (CORT) produced by a low dose of methamphetamine (METH). In the elevated plus maze, the acute administration of METH (0.1 mg/kg ip, -20...

DOI: 10.1016/s0091-3057(01)00564-0 (opens in new tab) Full text (opens in new tab) Iboga compounds Ibogaine derivatives Iboga alkaloids Stimulant addiction treatment +11

Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.

Psychopharmacology August 1, 2000 Karen K. Szumlinski, M Y Balogun, Isabelle M Maisonneuve et al. 28 citations

The phenomenon of sensitization has been theoretically implicated in mediating various aspects of drug addiction. Recent dose-response studies demonstrated that pretreatment with the putative antiaddictive agent, ibogaine (IBO), and a synthetic iboga alkaloid congener, 18-methoxycoronaridine (18-MC), increase the potency of cocaine to elicit behavioral sensitization, an effect proposed to...

DOI: 10.1007/s002130000478 (opens in new tab) Full text (opens in new tab) Stimulant misuse methamphetamine Stimulants Drug self-administration Chronic methamphetamine exposure +11